XKRX
001630
Market cap132mUSD
Oct 08, Last price
37,250.00KRW
1D
-0.80%
1Q
-5.46%
Jan 2017
-45.94%
Name
Chongkundang Holdings Corp
Chart & performance
P/E
4.39
P/S
0.18
EPS
8,492.65
Div yield, %
—
Shrs. gr., 5y
0.01%
Rev. gr., 5y
2.25%
Revenues
959.01b
+0.13%
Net income
40.43b
+20.34%
CFO
76.04b
+210.56%
Dividend
Mar 30, 20261400 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Seoul, South Korea, Chong Kun Dang Holdings Corp. has manufactured and supplied pharmaceutical goods since its inception in 1941, reaching both South Korean and global markets.
Key people
Chairman · since 2021
Jang Won Choi
Managing Director · since 2021
Seong Wuk Han
Managing Director · since 2023
Gi Seong Lee
Managing Director · since 2023
Yun Han Lee
Managing Director · since 2021
Jung Yong Cho
Internal Auditor
Hui Nam Choi
President, Chief Executive Officer, Director · since 2024
Wu Lee
Director · since 2025
Non-Executive Independent Director
Seung Yong Nah
Non-Executive Independent Director
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||